Genetic And Epigenetic Regulation Of Two Imprinted Tumor Suppressor Genes - Arhi And Peg3-In Ovarian Cancer

weiwei feng,rebecca t marquez,zhen lu,jinsong liu,karen h lu,yinhua yu,robert c bast

IF: 11.2

2006-01-01

Cancer Research

Abstract:1573 Genomic imprinting plays an important role in mammalian development, growth, cell differentiation and carcinogenesis. Imprinted tumor suppressor genes may be particularly important in the pathogenesis of ovarian cancer where strong chemical or viral carcinogens have not been implicated. In this study, we have documented decreased expression, CpG island hypermethylation and LOH for two imprinted tumor suppressor genes, ARHI and PEG3, in human ovarian cancers. Expression was measured by real time RT-PCR, methylation was quantitated by pyrosequencing and LOH was detected by electrophoresis and allele scoring with intragenic TA repeats and other polymorphic markers in 10 ovarian cancer cells lines, 42 pairs of normal and ovarian cancer tissues from the same patients, 3 normal ovarian epithelial cell cultures and epithelial scrapings from 5 normal ovaries. ARHI was downregulated in 8 of 10 ovarian cancer cell lines and 72.5% of 40 evaluable cases. As an imprinted gene, both CpG islands of the ARHI promoter were partially methylated in all normal ovarian epithelial cells and normal tissues. ARHI CpG island I and II were hypermethylated in 28.6% and 10% cases of ovarian cancers respectively. ARHI expression was reduced in 11 of 12 cases (91.7%) of ovarian cancer with CpG island I hypermethylation, and all 4 cases with CpG island II hypermethylation. LOH was found in 8 of 35 (23%) informative cases. The 4 cases with CpG island II hypermethylation had LOH, suggesting that hypermethylation and silencing could result from loss of the functional paternal allele. PEG3 expression was downregulated in 6 of 10 ovarian cancer cell lines and in 77.5% of 40 evaluable ovarian cancer cases. As a maternally imprinted gene, PEG3 was partially methylated in all normal ovarian epithelial cells. PEG3 was hypermethylated in 8 of 10 ovarian cancer cell lines and 31% of 42 ovarian cancers; 2 ovarian cancer cases (4.76%) were hypomethylated. PEG3 expression was downregulated in 12 of 13 hypermethylated cases (92.31%). In 25 informative cases, we found LOH in 5 cases (20%). PEG3 expression was downregulated in 4 of these 5 cases. Thus, a majority of ovarian cancers had downregulation of two imprinted tumor suppressor genes. Aberrant methylation and loss of heterozygosity were associated with decreased expression of these genes.